8-K filed March 6, 2025, 6:59 PM ET ticker WGRX CIK 0002030763

leadership confidence high sentiment positive materiality 0.70

Wellgistics Health appoints Brian Norton as CEO, partners with Protega to distribute ROXYBOND

Wellgistics Health, Inc.

Brian Norton promoted to CEO, succeeding Timothy Canning; no disagreement cited.
Norton's employment agreement: $490k base salary, performance bonus up to 100%, 9M RSUs vesting over 3 years.
Wellgistics LLC collaborates with Protega to distribute ROXYBOND, the first FDA-approved abuse-deterrent IR opioid.
Collaboration includes pharmacist education on abuse-deterrent options and regulatory compliance.
Wellgistics serves over 5,400 independent pharmacies across all 50 states.

item 1.01 item 5.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-009442
form_type: 8-K
ticker: WGRX
cik: 0002030763
company_name: Wellgistics Health, Inc.
filed_at: 2025-03-06T23:59:59+00:00
discovered_at: 2026-05-14T18:03:05.833144+00:00
generated_at: 2026-05-25T07:52:58.870834+00:00
sec_items: ["1.01", "5.02", "7.01", "9.01"]
event_type: leadership
sentiment: positive
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-009442
json_url: https://secwatch.observer/filing/0001493152-25-009442.json
markdown_url: https://secwatch.observer/filing/0001493152-25-009442.md
text_url: https://secwatch.observer/filing/0001493152-25-009442.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315225009442/0001493152-25-009442-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315225009442/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Timothy Canning

Chief Executive Officer

WGRX · Wellgistics Health, Inc.

Effective: 2025-02-28
Successor: Brian Norton
Filed: March 6, 2025, 6:59 PM ET

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Appointed

Brian Norton

Chief Executive Officer

WGRX · Wellgistics Health, Inc.

Effective: 2025-02-28
Filed: March 6, 2025, 6:59 PM ET

promoted Brian Norton to serve as the Company’s Chief Executive Officer effective as of February 28, 2025

Source-grounded claims

4c654da5e5

Timothy Canning departed as Chief Executive Officer at Wellgistics Health, Inc..

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

b7bdbe4a78

Brian Norton was appointed as Chief Executive Officer at Wellgistics Health, Inc..

promoted Brian Norton to serve as the Company’s Chief Executive Officer effective as of February 28, 2025

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

COR

Cencora appoints Eva Boratto as EVP and CFO, effective June 29, 2026; reaffirms FY2026 EPS guidance $17.70-$17.90

Cencora, Inc. May 29, 2026, 5:10 PM ET leadership Items 5.02, 1.01, 7.01, 9.01

same fact type: executive_change same SEC item: 1.01, 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).

Filing page SEC filing

BTMD

Biote CEO Christensen resigns; CFO Peterson named Interim CEO; Marc Beer Executive Chairman; FY2026 guidance reaffirmed

biote Corp. June 2, 2026, 5:17 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

On June 1, 2026, the Board appointed Marc Beer as Executive Chairman of the Board, effective June 8, 2026.

Filing page SEC filing

CYCU

Cycurion appoints Ana Garcia as CFO; Alvin McCoy III transitions to strategic advisor

Cycurion, Inc. June 2, 2026, 4:43 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.

Filing page SEC filing

ARDT

Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance

Ardent Health, Inc. June 2, 2026, 4:23 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Filing page SEC filing

ALH

COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR

Alliance Laundry Holdings Inc. June 2, 2026, 9:16 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026

Filing page SEC filing

CRVL

CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026

CORVEL CORP June 1, 2026, 5:05 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.

Filing page SEC filing

WST

West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair

WEST PHARMACEUTICAL SERVICES INC June 1, 2026, 4:32 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.

Filing page SEC filing

LPX

LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026

LOUISIANA-PACIFIC CORP June 1, 2026, 4:31 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

This filing

Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.

Comparable filing

On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-25-009442

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.